Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | XS27B | — |
expiration date was on 17 March 2025, and it was administered to a 22 year old; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 22-year-old female patient who received HBV (Engerix B) (batch number XS27B, expiry date 17-MAR-2025) for prophylaxis. On 04-JUN-2025, the patient received the 1st dose of Engerix B. On 04-JUN-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: expiration date was on 17 March 2025, and it was administered to a 22 year old). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 04-JUN-2025 On 4 June 2025 a pharmacist of called to asked how to proceed after the administration of an expired dose of Engerix-B. The expiration date was on 17th March 2025, and it was administered to a 22 year-old female patient on 4 June 2025, which led to Expired vaccine used. It was for the first dose. The reporter was consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.